Drumming predicts Parkinson progression

Trial ID
NCT05971459
Official Title
A Study of the Efficacy of IAMT as an Assessment Tool for Prediction of Progression of Parkinson's Disease
Goal
Drumming predicts Parkinson progression
Phase
NA
Status
RECRUITING
Sponsor
Wilfrid Laurier University
Study Type
INTERVENTIONAL
Enrollment
50 participants
Conditions
Parkinson Disease
Interventions
Improvised Active Music Therapy

Summary For Families

Researchers want to know whether improvised active music therapy can serve as an assessment tool to help predict how Parkinson's will progress, by picking up subtle changes in movement, timing, and coordination. Participants will play rhythmic patterns on a drum set while researchers record motor timing, coordination, and stability, the idea being that these active music tasks may reveal small gait and motor-control changes that standard tests miss. The study is looking for about 50 people aged 50 and up with a clinical Parkinson's diagnosis who can walk 80 meters, sit for 30 minutes, speak English, score above 24 on the Montreal Cognitive Assessment, are willing to play drums, and who do not have other neurological disorders, certain psychotropic medications, or current/previous musical training.

Locations

  • Wilfrid Laurier University, Waterloo, Ontario, Canada

Frequently Asked Questions

What is this trial testing?
This trial is studying Improvised Active Music Therapy. Researchers want to know whether improvised active music therapy can serve as an assessment tool to help predict how Parkinson's will progress, by picking up subtle changes in movement, timing, and coordination. Participants will play rhythmic patterns on a drum set while researchers record motor timing, coordination, and stability, the idea being that these active music tasks may reveal small gait and motor-control changes that standard tests miss. The study is looking for about 50 people aged 50 and up with a clinical Parkinson's diagnosis who can walk 80 meters, sit for 30 minutes, speak English, score above 24 on the Montreal Cognitive Assessment, are willing to play drums, and who do not have other neurological disorders, certain psychotropic medications, or current/previous musical training.
Who can participate?
Participants must be at least 50 Years.
Where is this trial located?
This trial is recruiting at 1 location.
Does it cost anything to join?
No. There is no cost to participate. Study-related care and treatment are provided at no charge.
How long does the trial last?
This trial is estimated to last approximately 7 months.
Will I get the real drug or a placebo?
It depends on the trial design. Some Parkinson's trials are placebo controlled, meaning a portion of participants get an inactive comparison while others get the experimental treatment. Some use crossover designs so everyone eventually receives the active treatment at some point. Observational trials do not use a placebo at all because they are not testing a new treatment. The consent form for any specific trial spells out the design and your odds of being assigned to placebo before you enroll.
How often will I need to visit the study site?
Visit frequency varies by trial. Many Parkinson's studies require an in person visit every 4 to 12 weeks during the active treatment phase, with shorter or longer gaps depending on the design. The site coordinator can give you the full visit schedule before you sign anything, so you know what the time commitment looks like.
Can I leave the trial if I change my mind?
Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
Will travel or parking be reimbursed?
Many trials reimburse for parking, mileage, and sometimes lodging if the site is far from your home. Reimbursement policies vary by sponsor and site. When you contact the trial team, ask specifically what is covered and how reimbursement is processed.
Can my spouse or care partner come with me to visits?
In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.

Related Reading

View on ClinicalTrials.gov